Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3)
The Alzheimer’s Disease Neuroimaging Initiative (also known as ADNI) is a historic study of brain aging looking to help change the future for this disease.
Inclusion Criteria
- 55 to 90 years of age
Have a diagnosis of early AD, Mild Cognitive Impairment (MCI) or are cognitively normal
Are willing and able to undergo in-clinic assessments, memory testing and other test procedures
Have a study partner who can accompany you to all clinic visits
Are fluent in English or Spanish
This is a free study. No experimental medication will be involved. To learn more, please visit http://www.adni3.org/
Subscribe To Our Newsletter
Sign up to receive email updates on announcements, new services added, company updates & more!
Want to participate in a study?
Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.